377 related articles for article (PubMed ID: 29066880)
1. Impact of selective and nonselective beta-blockers on the risk of severe exacerbations in patients with COPD.
Huang YL; Lai CC; Wang YH; Wang CY; Wang JY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2017; 12():2987-2996. PubMed ID: 29066880
[TBL] [Abstract][Full Text] [Related]
2. β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations.
Farland MZ; Peters CJ; Williams JD; Bielak KM; Heidel RE; Ray SM
Ann Pharmacother; 2013 May; 47(5):651-6. PubMed ID: 23585645
[TBL] [Abstract][Full Text] [Related]
3. Long-term effects of beta-blocker use on lung function in Japanese patients with chronic obstructive pulmonary disease.
Oda N; Miyahara N; Ichikawa H; Tanimoto Y; Kajimoto K; Sakugawa M; Kawai H; Taniguchi A; Morichika D; Tanimoto M; Kanehiro A; Kiura K
Int J Chron Obstruct Pulmon Dis; 2017; 12():1119-1124. PubMed ID: 28435245
[TBL] [Abstract][Full Text] [Related]
4. Rates of hospitalizations and emergency department visits in patients with asthma and chronic obstructive pulmonary disease taking beta-blockers.
Brooks TW; Creekmore FM; Young DC; Asche CV; Oberg B; Samuelson WM
Pharmacotherapy; 2007 May; 27(5):684-90. PubMed ID: 17461703
[TBL] [Abstract][Full Text] [Related]
5. Validation of a New Risk Measure for Chronic Obstructive Pulmonary Disease Exacerbation Using Health Insurance Claims Data.
Stanford RH; Nag A; Mapel DW; Lee TA; Rosiello R; Vekeman F; Gauthier-Loiselle M; Duh MS; Merrigan JF; Schatz M
Ann Am Thorac Soc; 2016 Jul; 13(7):1067-75. PubMed ID: 27070274
[TBL] [Abstract][Full Text] [Related]
6. Beta-blocker under-use in COPD patients.
Lim KP; Loughrey S; Musk M; Lavender M; Wrobel JP
Int J Chron Obstruct Pulmon Dis; 2017; 12():3041-3046. PubMed ID: 29089752
[TBL] [Abstract][Full Text] [Related]
7. Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.
Dong YH; Alcusky M; Maio V; Liu J; Liu M; Wu LC; Chang CH; Lai MS; Gagne JJ
BMJ Open; 2017 Mar; 7(3):e012997. PubMed ID: 28363921
[TBL] [Abstract][Full Text] [Related]
8. The association between inhaled corticosteroid and pneumonia in COPD patients: the improvement of patients' life quality with COPD in Taiwan (IMPACT) study.
Wang CY; Lai CC; Yang WC; Lin CC; Chen L; Wang HC; Yu CJ
Int J Chron Obstruct Pulmon Dis; 2016; 11():2775-2783. PubMed ID: 27877031
[TBL] [Abstract][Full Text] [Related]
9. Commencement of cardioselective beta-blockers during hospitalisation for acute exacerbations of chronic obstructive pulmonary disease.
Neef PA; Burrell LM; McDonald CF; Irving LB; Johnson DF; Steinfort DP
Intern Med J; 2017 Sep; 47(9):1043-1050. PubMed ID: 28608512
[TBL] [Abstract][Full Text] [Related]
10. β-Blockers and the Rate of Chronic Obstructive Pulmonary Disease Exacerbations.
Mersfelder TL; Shiltz DL
Ann Pharmacother; 2019 Dec; 53(12):1249-1258. PubMed ID: 31271049
[No Abstract] [Full Text] [Related]
11. The evaluation of β-adrenoceptor blocking agents in patients with COPD and congestive heart failure: a nationwide study.
Liao KM; Lin TY; Huang YB; Kuo CC; Chen CY
Int J Chron Obstruct Pulmon Dis; 2017; 12():2573-2581. PubMed ID: 28894360
[TBL] [Abstract][Full Text] [Related]
12. Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD).
Duffy S; Marron R; Voelker H; Albert R; Connett J; Bailey W; Casaburi R; Cooper JA; Curtis JL; Dransfield M; Han MK; Make B; Marchetti N; Martinez F; Lazarus S; Niewoehner D; Scanlon PD; Sciurba F; Scharf S; Reed RM; Washko G; Woodruff P; McEvoy C; Aaron S; Sin D; Criner GJ;
Respir Res; 2017 Jun; 18(1):124. PubMed ID: 28629419
[TBL] [Abstract][Full Text] [Related]
13. β-Blockers are associated with a reduction in COPD exacerbations.
Bhatt SP; Wells JM; Kinney GL; Washko GR; Budoff M; Kim YI; Bailey WC; Nath H; Hokanson JE; Silverman EK; Crapo J; Dransfield MT;
Thorax; 2016 Jan; 71(1):8-14. PubMed ID: 26283710
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD.
Lai CC; Wang YH; Wang CY; Wang HC; Yu CJ; Chen L
Int J Chron Obstruct Pulmon Dis; 2018; 13():867-874. PubMed ID: 29563786
[TBL] [Abstract][Full Text] [Related]
15. β-blockers after acute myocardial infarction in patients with chronic obstructive pulmonary disease: A nationwide population-based observational study.
Su TH; Chang SH; Kuo CF; Liu PH; Chan YL
PLoS One; 2019; 14(3):e0213187. PubMed ID: 30835781
[TBL] [Abstract][Full Text] [Related]
16. Use of beta blockers and the risk of death in hospitalised patients with acute exacerbations of COPD.
Dransfield MT; Rowe SM; Johnson JE; Bailey WC; Gerald LB
Thorax; 2008 Apr; 63(4):301-5. PubMed ID: 17951276
[TBL] [Abstract][Full Text] [Related]
17. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
18. Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease.
Rutten FH; Zuithoff NP; Hak E; Grobbee DE; Hoes AW
Arch Intern Med; 2010 May; 170(10):880-7. PubMed ID: 20498416
[TBL] [Abstract][Full Text] [Related]
19. Impact of β-blocker selectivity on long-term outcomes in congestive heart failure patients with chronic obstructive pulmonary disease.
Kubota Y; Asai K; Furuse E; Nakamura S; Murai K; Tsukada YT; Shimizu W
Int J Chron Obstruct Pulmon Dis; 2015; 10():515-23. PubMed ID: 25784798
[TBL] [Abstract][Full Text] [Related]
20. Association between β-blocker therapy and outcomes in patients hospitalised with acute exacerbations of chronic obstructive lung disease with underlying ischaemic heart disease, heart failure or hypertension.
Stefan MS; Rothberg MB; Priya A; Pekow PS; Au DH; Lindenauer PK
Thorax; 2012 Nov; 67(11):977-84. PubMed ID: 22941975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]